This course has expired. View available courses.
Endocrinology
A Guide to the Changing Diabetes Landscape: Translating the Latest Evidence into Practice
The diabetes landscape is rapidly changing. Since the 2018 Diabetes Canada guidelines were published, new evidence has emerged, prompting an update to the chapter on pharmacologic management of adults with type 2 diabetes (T2D). The two pillars of diabetes management include achieving glycemic targets and providing cardiovascular and renal protection. This program is designed to […]
DURATION
1 hr
PROFESSION
Physician
# OF CREDITS
1
ACCREDITATION
Mainpro+
EXPIRY DATE
2022-01-26
The diabetes landscape is rapidly changing. Since the 2018 Diabetes Canada guidelines were published, new evidence has emerged, prompting an update to the chapter on pharmacologic management of adults with type 2 diabetes (T2D). The two pillars of diabetes management include achieving glycemic targets and providing cardiovascular and renal protection.
This program is designed to discuss the updated recommendations from Diabetes Canada regarding the pharmacologic management of adults with T2D. The goal is for all participants to be able to incorporate guideline recommendations into their practice to ensure effective T2D management.
This program is developed in collaboration with M3 (EU) Ltd.
Supported by an education grant from Novo Nordisk A/S.
Faculty
Ronald Goldenberg, MD, FRCPC, FACE
Jeffrey Habert, MD, CCFP, FCFP
Jane Ballantine, MD
Daniel Ngui, MD, CCFP, FCFP
Learning objectives
After viewing the 4 expert brief videos in this program, participants will be better able to:
- Achieve glycemic targets in a timely fashion for patients with type 2 diabetes
- Apply Diabetes Canada recommendations for prescribing antihyperglycemic agents that provide cardiovascular and renal protection
- Counsel patients on common adverse events with GLP-1 RAs and SGLT2 inhibitors
- Identify patients and clinical situations in which it would be appropriate to prescribe combination therapy of GLP-1 RAs and SGLT2 inhibitors in type 2 diabetes
Accreditation
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1.0 Mainpro+ credit.
Cert+ Program ID#: 193592